Kee Woong Kwon

807 total citations
40 papers, 607 citations indexed

About

Kee Woong Kwon is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Kee Woong Kwon has authored 40 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 24 papers in Epidemiology and 20 papers in Immunology. Recurrent topics in Kee Woong Kwon's work include Tuberculosis Research and Epidemiology (31 papers), Mycobacterium research and diagnosis (20 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Kee Woong Kwon is often cited by papers focused on Tuberculosis Research and Epidemiology (31 papers), Mycobacterium research and diagnosis (20 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Kee Woong Kwon collaborates with scholars based in South Korea, United States and Australia. Kee Woong Kwon's co-authors include Sung Jae Shin, Hongmin Kim, Woo Sik Kim, Woo Sik Kim, Seung Jung Han, Hwa‐Jung Kim, Seung Bin, Han‐Gyu Choi, Sang‐Jun Ha and Hong Min Kim and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Kee Woong Kwon

39 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kee Woong Kwon South Korea 16 396 313 277 154 51 40 607
Björn Corleis Germany 14 336 0.8× 427 1.4× 246 0.9× 152 1.0× 51 1.0× 28 744
Eric Tibesar United States 4 230 0.6× 222 0.7× 253 0.9× 115 0.7× 44 0.9× 7 495
Scott M. Reba United States 12 248 0.6× 296 0.9× 184 0.7× 131 0.9× 50 1.0× 16 543
Jeremy Sousa Portugal 9 302 0.8× 229 0.7× 221 0.8× 127 0.8× 54 1.1× 13 517
Ulrike Zedler Germany 13 514 1.3× 467 1.5× 261 0.9× 145 0.9× 89 1.7× 18 760
Benjamin H. Gern United States 7 467 1.2× 361 1.2× 312 1.1× 227 1.5× 86 1.7× 22 788
Uma Devi Ranganathan India 15 357 0.9× 181 0.6× 265 1.0× 169 1.1× 101 2.0× 39 595
Tania Botha South Africa 9 497 1.3× 312 1.0× 410 1.5× 123 0.8× 135 2.6× 10 727
Marc A. Keen United States 10 528 1.3× 452 1.4× 411 1.5× 149 1.0× 108 2.1× 10 802
Raffaella Iantomasi Italy 13 353 0.9× 88 0.3× 297 1.1× 169 1.1× 76 1.5× 24 569

Countries citing papers authored by Kee Woong Kwon

Since Specialization
Citations

This map shows the geographic impact of Kee Woong Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kee Woong Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kee Woong Kwon more than expected).

Fields of papers citing papers by Kee Woong Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kee Woong Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kee Woong Kwon. The network helps show where Kee Woong Kwon may publish in the future.

Co-authorship network of co-authors of Kee Woong Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Kee Woong Kwon. A scholar is included among the top collaborators of Kee Woong Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kee Woong Kwon. Kee Woong Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwon, Kee Woong, Jii Bum Lee, Su Jin Jeong, et al.. (2025). Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosis. Nature Communications. 16(1). 8875–8875. 2 indexed citations
3.
Kwon, Kee Woong, et al.. (2024). Permissive lung neutrophils facilitate tuberculosis immunopathogenesis in male phagocyte NADPH oxidase-deficient mice. PLoS Pathogens. 20(8). e1012500–e1012500. 2 indexed citations
5.
Kwon, Kee Woong, Kyung Soo Kim, Insuk Lee, et al.. (2022). Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx. Nature Communications. 13(1). 3155–3155. 19 indexed citations
7.
Kwon, Kee Woong, Lee‐Han Kim, Ju Mi Lee, et al.. (2022). Host‐directed anti‐mycobacterial activity of colchicine, an anti‐gout drug, via strengthened host innate resistance reinforced by the IL‐1β/PGE2 axis. British Journal of Pharmacology. 179(15). 3951–3969. 9 indexed citations
8.
Kim, Lee‐Han, et al.. (2022). Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection. Antimicrobial Agents and Chemotherapy. 66(9). e0076222–e0076222. 2 indexed citations
9.
Park, Sang Chul, Dahee Shim, Ju Mi Lee, et al.. (2021). Exacerbation of Mycobacterium avium pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses. Virulence. 12(1). 2546–2561. 4 indexed citations
10.
Park, Sang Chul, Hongmin Kim, Dahee Shim, et al.. (2020). An Alternative Dendritic Cell-Induced Murine Model of Asthma Exhibiting a Robust Th2/Th17-Skewed Response. Allergy Asthma and Immunology Research. 12(3). 537–537. 24 indexed citations
11.
Choi, Han‐Gyu, Kee Woong Kwon, Seunga Choi, et al.. (2020). Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine. Vaccines. 8(2). 300–300. 27 indexed citations
13.
Kwon, Kee Woong, Sasha E. Larsen, Susan L. Baldwin, et al.. (2019). Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model. Scientific Reports. 9(1). 15560–15560. 37 indexed citations
14.
Kim, Woo Sik, Hongmin Kim, Kee Woong Kwon, Sang-Nae Cho, & Sung Jae Shin. (2019). Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent Mycobacterium tuberculosis Beijing K Strain. Frontiers in Microbiology. 10. 220–220. 11 indexed citations
15.
Kim, Woo Sik, In Duk Jung, Jong Seok Kim, et al.. (2018). Mycobacterium tuberculosis GrpE, A Heat-Shock Stress Responsive Chaperone, Promotes Th1-Biased T Cell Immune Response via TLR4-Mediated Activation of Dendritic Cells. Frontiers in Cellular and Infection Microbiology. 8. 95–95. 34 indexed citations
16.
17.
Choi, Han‐Gyu, Woo Sik Kim, Yong Woo Back, et al.. (2015). Mycobacterium tuberculosis RpfE promotes simultaneous Th1‐ and Th17‐type T‐cell immunity via TLR4‐dependent maturation of dendritic cells. European Journal of Immunology. 45(7). 1957–1971. 66 indexed citations
18.
Kim, Woo Sik, Hong Min Kim, Kee Woong Kwon, et al.. (2015). Mycobacterium tuberculosis MmsA, a novel immunostimulatory antigen, induces dendritic cell activation and promotes Th1 cell-type immune responses. Cellular Immunology. 298(1-2). 115–125. 12 indexed citations
19.
Kim, Woo Sik, Jong-Seok Kim, Seung Bin, et al.. (2015). Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection. Immunobiology. 221(3). 440–453. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026